berbamine has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, B; Chen, Q; Du, B; Jiang, Y; Li, C; Song, Y; Tan, Y; Wang, K; Wei, X; Xiao, J; Zhan, Y; Zhang, W; Zhao, T | 1 |
| Chen, C; Hou, ZB; Huang, XE; Lu, KJ; Wu, XL; Yin, HT | 1 |
2 other study(ies) available for berbamine and Lung Neoplasms
| Article | Year |
|---|---|
Berbamine Hydrochloride inhibits lysosomal acidification by activating Nox2 to potentiate chemotherapy-induced apoptosis via the ROS-MAPK pathway in human lung carcinoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Carcinoma; Cathepsins; Cisplatin; Humans; Hydrogen-Ion Concentration; Lung; Lung Neoplasms; Lysosomes; Mice; Reactive Oxygen Species | 2023 |
In vitro and in vivo antitumor evaluation of berbamine for lung cancer treatment.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Benzylisoquinolines; Calcium Channel Blockers; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Transplantation, Heterologous; Xenograft Model Antitumor Assays | 2014 |